BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 21752644)

  • 1. A mechanism-based potent sirtuin inhibitor containing Nε-thiocarbamoyl-lysine (TuAcK).
    Hirsch BM; Hao Y; Li X; Wesdemiotis C; Wang Z; Zheng W
    Bioorg Med Chem Lett; 2011 Aug; 21(16):4753-7. PubMed ID: 21752644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simple N(ε)-thioacetyl-lysine-containing cyclic peptides exhibiting highly potent sirtuin inhibition.
    Huang Y; Liu J; Yan L; Zheng W
    Bioorg Med Chem Lett; 2016 Mar; 26(6):1612-1617. PubMed ID: 26874402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The mimics of N
    Wang C; Wang F; Chen X; Zou Y; Zhu H; Zhao Q; Shen J; Li Y; Li Y; He B
    Bioorg Med Chem Lett; 2018 Aug; 28(14):2375-2378. PubMed ID: 29921476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel thiourea-based sirtuin inhibitory warheads.
    Zang W; Hao Y; Wang Z; Zheng W
    Bioorg Med Chem Lett; 2015 Aug; 25(16):3319-24. PubMed ID: 26081291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Selective Cyclic Peptidic Human SIRT5 Inhibitor.
    Liu J; Huang Y; Zheng W
    Molecules; 2016 Sep; 21(9):. PubMed ID: 27626398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism-based inhibition of Sir2 deacetylases by thioacetyl-lysine peptide.
    Smith BC; Denu JM
    Biochemistry; 2007 Dec; 46(50):14478-86. PubMed ID: 18027980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a cell-active non-peptide sirtuin inhibitor containing N-thioacetyl lysine.
    Suzuki T; Asaba T; Imai E; Tsumoto H; Nakagawa H; Miyata N
    Bioorg Med Chem Lett; 2009 Oct; 19(19):5670-2. PubMed ID: 19700324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel sirtuin inhibitory warheads derived from the N(ε)-acetyl-lysine analog L-2-amino-7-carboxamidoheptanoic acid.
    He Y; Yan L; Zang W; Zheng W
    Org Biomol Chem; 2015 Nov; 13(42):10442-50. PubMed ID: 26418815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of human sirtuins by in situ generation of an acetylated lysine-ADP-ribose conjugate.
    Asaba T; Suzuki T; Ueda R; Tsumoto H; Nakagawa H; Miyata N
    J Am Chem Soc; 2009 May; 131(20):6989-96. PubMed ID: 19413317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of new human Sirtuin 5 inhibitors by mimicking glutaryl-lysine substrates.
    Yang F; Su H; Deng J; Mou L; Wang H; Li R; Dai QQ; Yan YH; Qian S; Wang Z; Li GB; Yang L
    Eur J Med Chem; 2021 Dec; 225():113803. PubMed ID: 34461505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N(epsilon)-thioacetyl-lysine-containing tri-, tetra-, and pentapeptides as SIRT1 and SIRT2 inhibitors.
    Kiviranta PH; Suuronen T; Wallén EA; Leppänen J; Tervonen J; Kyrylenko S; Salminen A; Poso A; Jarho EM
    J Med Chem; 2009 Apr; 52(7):2153-6. PubMed ID: 19296597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential modulation of SIRT6 deacetylase and deacylase activities by lysine-based small molecules.
    Sociali G; Liessi N; Grozio A; Caffa I; Parenti MD; Ravera S; Tasso B; Benzi A; Nencioni A; Del Rio A; Robina I; Millo E; Bruzzone S
    Mol Divers; 2020 Aug; 24(3):655-671. PubMed ID: 31240519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and characterization of lysine based tripeptide analogues as inhibitors of Sir2 activity.
    Chakrabarty SP; Ramapanicker R; Mishra R; Chandrasekaran S; Balaram H
    Bioorg Med Chem; 2009 Dec; 17(23):8060-72. PubMed ID: 19861237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sirtuin Inhibition: Strategies, Inhibitors, and Therapeutic Potential.
    Jiang Y; Liu J; Chen D; Yan L; Zheng W
    Trends Pharmacol Sci; 2017 May; 38(5):459-472. PubMed ID: 28389129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxadiazole-carbonylaminothioureas as SIRT1 and SIRT2 inhibitors.
    Huhtiniemi T; Suuronen T; Rinne VM; Wittekindt C; Lahtela-Kakkonen M; Jarho E; Wallén EA; Salminen A; Poso A; Leppänen J
    J Med Chem; 2008 Aug; 51(15):4377-80. PubMed ID: 18642893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thiosuccinyl peptides as Sirt5-specific inhibitors.
    He B; Du J; Lin H
    J Am Chem Soc; 2012 Feb; 134(4):1922-5. PubMed ID: 22263694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A bicyclic pentapeptide-based highly potent and selective pan-SIRT1/2/3 inhibitor harboring N
    Li R; Yan L; Sun X; Zheng W
    Bioorg Med Chem; 2020 Apr; 28(7):115356. PubMed ID: 32067892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human SIRT3 tripeptidic inhibitors containing N(ε)-thioacetyl-lysine.
    Chen B; Wang J; Huang Y; Zheng W
    Bioorg Med Chem Lett; 2015 Sep; 25(17):3481-7. PubMed ID: 26220157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Substrates for efficient fluorometric screening employing the NAD-dependent sirtuin 5 lysine deacylase (KDAC) enzyme.
    Madsen AS; Olsen CA
    J Med Chem; 2012 Jun; 55(11):5582-90. PubMed ID: 22583019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Small molecule inhibitors of HIV RT Ribonuclease H.
    Di Grandi M; Olson M; Prashad AS; Bebernitz G; Luckay A; Mullen S; Hu Y; Krishnamurthy G; Pitts K; O'Connell J
    Bioorg Med Chem Lett; 2010 Jan; 20(1):398-402. PubMed ID: 19939680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.